CausalSentinel

Protein Dossier — F11 (Coagulation factor XI)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: hypopituitarism 0.382 0.131 0.00356 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: hypopituitarism 0.382 0.131 0.00356 Inverse variance weighted 2 cis NA
Eczema 0.066 0.0245 0.00717 Inverse variance weighted 2 trans NA
Eczema 0.066 0.0245 0.00717 Inverse variance weighted 2 cis NA
Years of schooling 0.014 0.00562 0.0124 Inverse variance weighted 2 trans NA
Years of schooling 0.014 0.00562 0.0124 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: I80 Phlebitis and thrombophlebitis 0.252 0.107 0.0181 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: I80 Phlebitis and thrombophlebitis 0.252 0.107 0.0181 Inverse variance weighted 2 cis NA
Paget’s disease 0.201 0.0877 0.0219 Inverse variance weighted 2 trans NA
Paget’s disease 0.201 0.0877 0.0219 Inverse variance weighted 2 cis NA
Vascular or heart problems diagnosed by doctor: Angina -0.0445 0.0203 0.0289 Inverse variance weighted 2 trans NA
Vascular or heart problems diagnosed by doctor: Angina -0.0445 0.0203 0.0289 Inverse variance weighted 2 cis NA
…and 185 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2190_55_1 Coagulation Factor XI Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

180 association rows across 88 traits (148 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Coagulation Factor XI levels 2e-272 rs2289252 6 GCST90247103 no MR -> candidate analysis
Venous thromboembolism 4e-256 rs3756011 15 GCST90797305 no MR -> candidate analysis
Venous thromboembolism or factor XI levels (pleiotropy) 1e-251 rs3756011 1 GCST90129538 no MR -> candidate analysis
Fibrinogen levels or factor VII levels or factor XI levels o 4e-199 rs4253417 1 GCST90129560 no MR -> candidate analysis
Ischemic stroke or factor XI levels (pleiotropy) 1e-197 rs4253417 1 GCST90129552 no MR -> candidate analysis
Factor XI 3e-193 rs4253417 1 GCST004124 no MR -> candidate analysis
Coronary artery disease or factor XI levels (pleiotropy) 9e-189 rs4253417 1 GCST90129545 no MR -> candidate analysis
Vertex-wise sulcal depth 3e-139 rs62348889 2 GCST90095129 no MR -> candidate analysis
Other venous embolism and thrombosis (PheCode 452) 8e-127 rs3756011 3 GCST90476007 no MR -> candidate analysis
Serum levels of protein F11 7e-125 rs2289252 2 GCST90087924 no MR -> candidate analysis
F11 protein levels 8e-125 rs6848311 10 GCST90469165 no MR -> candidate analysis
Deep vein thrombosis [DVT] (PheCode 452.2) 6e-98 rs4444878 2 GCST90476010 no MR -> candidate analysis
…and 76 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 306 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
factor XI deficiency 0.964 0.901 established (curated) no MR -> candidate analysis
congenital factor XI deficiency 0.877 established (curated) no MR -> candidate analysis
venous thromboembolism 0.922 common-variant locus no MR -> candidate analysis
deep vein thrombosis 0.901 common-variant locus no MR -> candidate analysis
pulmonary embolism 0.888 common-variant locus MR: beta=0.237, p=0.102 (trans)
heart disorder 0.878 common-variant locus no MR -> candidate analysis
phlebitis 0.876 common-variant locus MR: beta=0.252, p=0.0181 (trans)
Thrombophlebitis 0.869 common-variant locus MR: beta=0.252, p=0.0181 (trans)
cardiovascular disorder 0.827 common-variant locus no MR -> candidate analysis
Thromboembolism 0.819 common-variant locus no MR -> candidate analysis
ischemic stroke 0.777 common-variant locus MR: beta=0.0396, p=0.0952 (trans)
Abnormal bleeding 0.803 established (curated) no MR -> candidate analysis
Pulmonary Infarction 0.801 common-variant locus no MR -> candidate analysis
thrombophilia 0.781 common-variant locus no MR -> candidate analysis
hereditary disease 0.772 established (curated) no MR -> candidate analysis

Of the 15 rows above, 11 have no MR estimate in this resource. Across all retrieved diseases for this gene: 1 exploratory rare-variant signal(s), 1 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 4 known modulators (Coagulation factor XI)
gnomAD constraint pLI=1.8e-27, LOEUF=1.23 — LoF-tolerant
GWAS Catalog 128 unique SNPs / 302 rows
ClinVar 972 records; 23 pathogenic in sample of 30
PharmGKB/ClinPGx 1 clinical annotations across 1 drugs

Caveats declared by the tools

Sources

Provenance